Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Sensus Healthcare develops non-invasive, cost-effective superficial radiation therapy (SRT) devices for treating skin conditions like non-melanoma skin cancer and keloids. Its products serve dermatology and radiation oncology markets worldwide, offering safe, effective alternatives to surgery and traditional radiation. The company emphasizes proprietary technology, regulatory compliance, and global distribution, focusing on clinical outcomes, ease of use, and expanding aesthetic and medical applications.
This description was generated via AI from an annual report. Updated about 1 year ago.